A federal judge has awarded Takeda Pharmaceutical $16.8 million plus interest in legal and expert fees in a patent infringement case.

Southern District of New York Judge Denise Cote, in Takeda Chemical Industries v. Mylan Laboratories, 03 Civ. 8253, said the defendant generic drug companies acted with “exceptional misconduct and bad faith” by attempting to infringe on Takeda’s patent on a chemical compound used in the treatment of diabetes.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]